Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis

BACKGROUND: Immunotherapy has been shown to reduce relapses in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder (MOG-AD); however, the superiority of specific treatments remains unclear. AIM: To identify the efficacy and tolerability of different treatments for MOG-AD....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaofei, Kong, Lingyao, Zhao, Zhengyang, Shi, Ziyan, Chen, Hongxi, Lang, Yanlin, Lin, Xue, Du, Qin, Zhou, Hongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360318/
https://www.ncbi.nlm.nih.gov/pubmed/35958613
http://dx.doi.org/10.3389/fimmu.2022.953993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360318/
https://www.ncbi.nlm.nih.gov/pubmed/35958613
http://dx.doi.org/10.3389/fimmu.2022.953993

Ejemplares similares